Welcome to our dedicated page for Medical Care Technologies news (Ticker: MDCE), a resource for investors and traders seeking the latest updates and insights on Medical Care Technologies stock.
Medical Care Technologies Inc. develops and commercializes artificial intelligence applications across consumer software, imaging analysis, healthcare-oriented pre-screening and collectibles authentication. News about MDCE centers on its AI technology stack, including Snapshot Recipes, a mobile recipe application with AI-generated food and beverage content, and Real Game Used, a subsidiary developing a patent-pending AI authentication platform for sports memorabilia.
Company updates also cover AI imaging initiatives for dermatological analysis, wellness monitoring, product verification and automated quality control, as well as capital and asset-monetization activity through Infinite Auctions. Recurring announcements describe product redesigns, commercialization pathways, subsidiary activity, mobile-app user growth initiatives, and enterprise API or visual analytics use cases.
Medical Care Technologies (OTC PINK:MDCE) subsidiary Infinite Auctions will feature Carmelo Anthony's photo-matched, MeiGray-authenticated jersey from his final New York Knicks game in an upcoming premier auction.
The April 12, 2017 Madison Square Garden game-worn piece is positioned as a rare, high-profile memorabilia offering.
Medical Care Technologies (OTC: MDCE) announced expanded marketing initiatives for its flagship AI mobile app, Snapshot Recipes, on June 17, 2026. The app uses artificial intelligence and image recognition to turn photos of groceries, ingredients, or refrigerator contents into personalized recipes from global cuisines.
Available on Apple iOS and Android, Snapshot Recipes aims to simplify meal planning and help users maximize existing ingredients. The company is hiring a full-time social media manager to drive brand awareness, user engagement, and content creation across TikTok, Instagram, and other platforms as part of its broader AI consumer strategy.
Medical Care Technologies (OTC PINK:MDCE) outlined the privacy-focused architecture for its MDCE Melanoma Scan Beta AI imaging platform. The company is emphasizing secure image handling, user authentication, access controls, data governance, and scalable software design to support future compliance, platform growth, and user confidence.
Medical Care Technologies (OTC PINK:MDCE), via subsidiary Infinite Auctions, is offering Kobe Bryant’s photo-matched, dual-signed Adidas “The Kobe 1” sneakers worn in Game 5 of the 2001 NBA Finals. Bidding starts at $10,000 with a $240,000 Buy-It-Now and part of the proceeds will benefit the Lakers Youth Foundation.
Medical Care Technologies (OTC PINK:MDCE) began advanced internal beta testing of its MDCE Melanoma Scan imaging platform. The AI-assisted system is being evaluated for stability, workflow performance, image management, interface responsiveness, and image consistency.
The beta-stage pre-screening platform supports longitudinal image organization, is part of a broader AI imaging and digital wellness strategy, is not intended to treat or cure disease, and has not been reviewed or cleared by the FDA.
Medical Care Technologies (OTC:MDCE) launched a redesigned Infinite Auctions platform for premium sports memorabilia, using straight bidding and real-time Buy It Now instead of proxy bidding.
The NBA Game Used Flash Auction 2026 runs June 27–July 18, highlights $3M+ historical sales, and will help liquidate $50,000–$150,000 of company-owned collectibles.
Medical Care Technologies (OTC PINK:MDCE) outlined its long-term AI vision for the MDCE Melanoma Scan Beta platform and related imaging initiatives. The company positions the beta platform as a foundation for future AI-assisted imaging, image management, and analysis frameworks focused on wellness-oriented, preventative, and consumer health applications.
Current efforts center on development, testing, refinement, and evaluation, with future uses dependent on research progress, resources, regulation, and market conditions. The beta platform is not FDA cleared and is not intended for diagnosis or treatment.
Medical Care Technologies (OTC PINK:MDCE) outlined user experience and interface design goals for its Melanoma Scan Beta platform. Current work centers on streamlined image organization, interactive body-map tracking, and long-term visual monitoring workflows.
The beta platform is under internal evaluation, supports AI-assisted imaging initiatives, and is not intended for diagnosis or treatment and has not been reviewed or cleared by the FDA.
Medical Care Technologies (OTC PINK:MDCE) outlined design and development details for its MDCE Melanoma Scan Beta imaging platform. The beta-stage AI-assisted body-map application focuses on organizing skin images and supporting longitudinal visual tracking while remaining a non-diagnostic, pre-screening tool without FDA review or clearance.
Medical Care Technologies (OTC Pink: MDCE) generated approximately $250,000 in non-dilutive capital through subsidiary asset sales and related operating activities at Infinite Auctions and Real Game Used.
The company plans to use these funds for AI product development, commercialization and marketing, reducing corporate obligations, and supporting operational growth as part of a broader internal capital generation initiative.